Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. [electronic resource]
Producer: 20200302Description: 1708-1711 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Aged, 80 and over
- Benzoates -- adverse effects
- Blood Platelets -- drug effects
- Chronic Disease
- Female
- Humans
- Hydrazines -- adverse effects
- Lymphoproliferative Disorders -- complications
- Male
- Middle Aged
- Prospective Studies
- Purpura, Thrombocytopenic, Idiopathic -- complications
- Pyrazoles -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.